Arrhythmogenic Cardiomyopathy: Atorvastatin Study

We are evaluating whether atorvastatin can help slow down heart function decline in people with Arrhythmogenic Cardiomyopathy. The study also looks at its safety and effects on heart-related markers.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Atorvastatin Actavis
Atorvastatin Actavis is a medicine that helps lower cholesterol and reduce the risk of heart disease.
Atorvastatina Teva Italia
Atorvastatina Teva Italia is a medicine that lowers cholesterol to help reduce the risk of heart disease and stroke.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Atorvastatin
Atorvastatin is a substance that lowers bad cholesterol to help reduce the risk of heart attacks and strokes.
Atorvastatin Calcium
Atorvastatin calcium is a substance that lowers "bad" cholesterol to help reduce the risk of heart attack and stroke.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Abator
Altoram
Altrexyl

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Azienda Ospedaliero Universitaria Delle Marche
Clinical, Special and Dental Sciences
Ancona, Italy
Fondazione IRCCS Policlinico San Matteo
U.O. di Cardiologia
Pavia, Italy
Azienda Ospedaliera Universitaria Federico II Di Napoli
Dipartimento di Scienze Biomediche Avanzate
Piscinola, Italy

Sponsor: Centro Cardiologico Monzino S.p.A.
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.